At day 24 the DR500 suppressive effect on Gr1+CD11b+ cells disappeared and the inductive effect on CD4+, CD8+ T and B lymphocytes was attenuated at all sites, particularly in the primary tumor, compared to MR20-injected mice (Supplementary Fig. 4a, b, c). This evidence concerns the gene CD8A and neoplasm.